# Omeros Corp: filings

OMER · Nasdaq · CIK 1285819 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/omer.md) · [Financials](/companies/omer/financials.md) · [Filings](/companies/omer/filings.md) · [Insiders](/companies/omer/insiders.md)

## Reports and events: 274 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 277, 8-K 181, 10-Q 51, SC 13G/A 46, 424B5 28, CT ORDER 27, 10-K 17, 3 17, DEF 14A 17, 144 15, SC 13G 15, S-8 14, ARS 10, UPLOAD 9, 424B3 7, CORRESP 7, EFFECT 6, FWP 4, S-1/A 4, S-3ASR 4, SCHEDULE 13G/A 4, POS AM 3, POSASR 3, S-3 3, 10-K/A 2, D 2, RW 2, 305B2 1, 424B4 1, 4/A 1, 8-A12B 1, 8-K/A 1, AW 1, CERTNAS 1, DEFA14A 1, NO ACT 1, S-1 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 17:01 ET | [8-K](/filings/0001552781-26-000531.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001552781-26-000531 |
| 2026-08-13 | 16:05 ET | [8-K](/filings/0001552781-26-000441.md) | 5.02 Departure or appointment of officers or directors | 0001552781-26-000441 |
| 2026-08-12 | 16:12 ET | [10-Q](/filings/0001437749-26-027318.md) | Quarterly report, period 2026-06-30 | 0001437749-26-027318 |
| 2026-08-12 | 16:09 ET | [8-K](/filings/0001437749-26-027313.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-027313 |
| 2026-07-20 | 17:05 ET | [8-K](/filings/0001437749-26-023886.md) | 8.01 Other events | 0001437749-26-023886 |
| 2026-07-06 | 08:30 ET | [8-K](/filings/0001552781-26-000377.md) | 8.01 Other events | 0001552781-26-000377 |
| 2026-06-25 | 06:02 ET | [8-K](/filings/0001437749-26-021617.md) | 5.07 Shareholder vote results | 0001437749-26-021617 |
| 2026-06-18 | 07:52 ET | [8-K](/filings/0001437749-26-021040.md) | 8.01 Other events | 0001437749-26-021040 |
| 2026-05-13 | 16:07 ET | [10-Q](/filings/0001437749-26-016720.md) | Quarterly report, period 2026-03-31 | 0001437749-26-016720 |
| 2026-05-13 | 16:06 ET | [8-K](/filings/0001437749-26-016718.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-016718 |
| 2026-04-30 | 08:00 ET | [DEF 14A](/filings/0001552781-26-000281.md) | Proxy statement, period 2026-06-18 | 0001552781-26-000281 |
| 2026-03-31 | 16:06 ET | [10-K](/filings/0001437749-26-010636.md) | Annual report, period 2025-12-31 | 0001437749-26-010636 |
| 2026-03-31 | 16:05 ET | [8-K](/filings/0001437749-26-010634.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-010634 |
| 2026-01-07 | 17:15 ET | [8-K](/filings/0001437749-26-000820.md) | 2.02 Results of operations | 0001437749-26-000820 |
| 2025-12-29 | 06:08 ET | [8-K](/filings/0001437749-25-038758.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-038758 |
| 2025-12-01 | 08:30 ET | [8-K](/filings/0001437749-25-036507.md) | 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-036507 |
| 2025-11-13 | 16:11 ET | [10-Q](/filings/0001437749-25-034826.md) | Quarterly report, period 2025-09-30 | 0001437749-25-034826 |
| 2025-11-13 | 16:09 ET | [8-K](/filings/0001437749-25-034824.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-034824 |
| 2025-10-15 | 08:30 ET | [8-K](/filings/0001437749-25-030968.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-030968 |
| 2025-08-14 | 16:09 ET | [10-Q](/filings/0001437749-25-026933.md) | Quarterly report, period 2025-06-30 | 0001437749-25-026933 |
| 2025-08-14 | 16:06 ET | [8-K](/filings/0001437749-25-026931.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-026931 |
| 2025-07-25 | 08:10 ET | [8-K](/filings/0001104659-25-070554.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-070554 |
| 2025-07-02 | 16:07 ET | [8-K](/filings/0001437749-25-021959.md) | 5.07 Shareholder vote results | 0001437749-25-021959 |
| 2025-05-30 | 16:37 ET | [DEF 14A](/filings/0001140361-25-020948.md) | Proxy statement, period 2025-06-27 | 0001140361-25-020948 |
| 2025-05-16 | 16:29 ET | [8-K/A](/filings/0001437749-25-017426.md) | 9.01 Financial statements and exhibits | 0001437749-25-017426 |
| 2025-05-15 | 16:32 ET | [10-Q](/filings/0001437749-25-017213.md) | Quarterly report, period 2025-03-31 | 0001437749-25-017213 |
| 2025-05-15 | 16:31 ET | [8-K](/filings/0001437749-25-017211.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-017211 |
| 2025-05-06 | 17:00 ET | [8-K](/filings/0001437749-25-014815.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-014815 |
| 2025-04-30 | 17:08 ET | [10-K/A](/filings/0001437749-25-013902.md) | Annual report, amended, period 2024-12-31 | 0001437749-25-013902 |
| 2025-03-31 | 16:28 ET | [10-K](/filings/0001437749-25-010216.md) | Annual report, period 2024-12-31 | 0001437749-25-010216 |
| 2025-03-31 | 16:25 ET | [8-K](/filings/0001437749-25-010211.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-010211 |
| 2025-02-20 | 09:15 ET | [8-K](/filings/0001437749-25-004505.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-004505 |
| 2025-01-16 | 09:25 ET | [8-K](/filings/0001437749-25-001245.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-001245 |
| 2024-12-19 | 09:20 ET | [8-K](/filings/0001437749-24-037898.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-037898 |
| 2024-11-13 | 16:08 ET | [10-Q](/filings/0001437749-24-034903.md) | Quarterly report, period 2024-09-30 | 0001437749-24-034903 |
| 2024-11-13 | 16:06 ET | [8-K](/filings/0001437749-24-034900.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-034900 |
| 2024-08-07 | 16:08 ET | [10-Q](/filings/0001437749-24-025181.md) | Quarterly report, period 2024-06-30 | 0001437749-24-025181 |
| 2024-08-07 | 16:06 ET | [8-K](/filings/0001437749-24-025179.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-025179 |
| 2024-06-12 | 16:48 ET | [8-K](/filings/0001437749-24-020102.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001437749-24-020102 |
| 2024-06-03 | 09:00 ET | [8-K](/filings/0001437749-24-018964.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-018964 |
| 2024-05-15 | 16:09 ET | [10-Q](/filings/0001437749-24-017047.md) | Quarterly report, period 2024-03-31 | 0001437749-24-017047 |
| 2024-05-15 | 16:07 ET | [8-K](/filings/0001437749-24-017044.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-017044 |
| 2024-04-29 | 17:23 ET | [DEF 14A](/filings/0001437749-24-013762.md) | Proxy statement, period 2024-06-06 | 0001437749-24-013762 |
| 2024-04-01 | 17:20 ET | [10-K](/filings/0001437749-24-010416.md) | Annual report, period 2023-12-31 | 0001437749-24-010416 |
| 2024-04-01 | 16:06 ET | [8-K](/filings/0001437749-24-010359.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-010359 |
| 2024-02-07 | 08:00 ET | [8-K](/filings/0001437749-24-003287.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001437749-24-003287 |
| 2023-11-09 | 16:06 ET | [10-Q](/filings/0001437749-23-031250.md) | Quarterly report, period 2023-09-30 | 0001437749-23-031250 |
| 2023-11-09 | 16:05 ET | [8-K](/filings/0001437749-23-031249.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-031249 |
| 2023-10-16 | 16:36 ET | [8-K](/filings/0001437749-23-028296.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-028296 |
| 2023-08-09 | 08:05 ET | [10-Q](/filings/0001558370-23-014095.md) | Quarterly report, period 2023-06-30 | 0001558370-23-014095 |

Page 1 of 6. [Older](/companies/omer/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 17:13 ET. No prices; not investment advice.